Latest News in the pharma Industry

Market News

Teva launches generic version of Reyataz in the US

Teva launches generic version of Reyataz in the US

28 Dec 2017

The exclusive launch of Teva's generic version of Reyataz marks the company's fifth generic product offering for the treatment of HIV-1 infection.

Read more 
Novartis drug Tasigna approved by FDA

Novartis drug Tasigna approved by FDA

28 Dec 2017

First and only CML therapy with Treatment-free Remission data in its label.

Read more 
FDA approves the only OTC eye drop with low-dose Brimonidine to treat eye redness

FDA approves the only OTC eye drop with low-dose Brimonidine to treat eye redness

27 Dec 2017

Clinical studies showed 95% symptom improvement at one minute and reduced redness for up t 8 hours.

Read more 
AMSBIO introduces highly efficient substrate for culturing ES/iPS cells

AMSBIO introduces highly efficient substrate for culturing ES/iPS cells

27 Dec 2017

iMatrix recombinant Laminin-511 E8 protein fragments permit ES/iPS cells to be maintained in xeno-free, feeder-free culture conditions enabling easy application in medical trials.

Read more 
Allergan acknowledges Appeals Court decision for Combigan

Allergan acknowledges Appeals Court decision for Combigan

27 Dec 2017

Allergan plans to file petitions for rehearing of the appeals court decision and has asserted a new Orange Book patent against Sandoz's generic version of Combigan.

Read more 
Crown Bioscience and JSR Corporation to merge

Crown Bioscience and JSR Corporation to merge

21 Dec 2017

Merger integrates Crown Bioscience’s leading translational technology platform providing drug target validation, efficacy testing and patient response characterization with JSR’s IVD solutions, GMP manufacturing capabilities and worldwide distribution ...

Read more 
Biogen and Ionis collaborate to identify novel therapies for the treatment of SMA

Biogen and Ionis collaborate to identify novel therapies for the treatment of SMA

21 Dec 2017

New collaboration agreement to identify new antisense oligonucleotide drug candidates.

Read more 
FDA clears myPKFiT for ADVATE to help personalize care for hemophilia A

FDA clears myPKFiT for ADVATE to help personalize care for hemophilia A

19 Dec 2017

First and only FDA-cleared PK dosing software to support healthcare professionals in creating personalized dosing regimens for patients 16 and older with hemophilia A.

Read more 
Major changes for bio supply forecast in 2018 by bioLIVE

Major changes for bio supply forecast in 2018 by bioLIVE

19 Dec 2017

Integration of supply chain a critical issue as industry globalises, with a resurgence in European manufacturing and biotech markets forecast.

Read more 
Hikma signs licensing agreement with Celltrion for third biosimilar product in MENA region

Hikma signs licensing agreement with Celltrion for third biosimilar product in MENA region

19 Dec 2017

Truxima is mAb biosimilar to Roche's MabThera (rituximab).

Read more 
Teva to axe 25% of its total workforce

Teva to axe 25% of its total workforce

18 Dec 2017

Total cost base to be reduced by $3 billion by the end of 2019.

Read more 
Femarelle launches new women’s supplement line in US

Femarelle launches new women’s supplement line in US

18 Dec 2017

Targeted formulas support symptoms before, during and after menopause.

Read more